日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/07/06 | 7,100 | 7,190 | 7,080 | 7,130 | +80 | +1.1% | 235,900 |
| 2017/07/05 | 7,070 | 7,080 | 6,970 | 7,050 | -20 | -0.3% | 178,700 |
| 2017/07/04 | 7,230 | 7,240 | 7,050 | 7,070 | -120 | -1.7% | 139,500 |
| 2017/07/03 | 7,230 | 7,240 | 7,170 | 7,190 | ±0 | ±0% | 164,300 |
| 2017/06/30 | 7,210 | 7,240 | 7,130 | 7,190 | -30 | -0.4% | 204,500 |
| 2017/06/29 | 7,230 | 7,270 | 7,170 | 7,220 | +20 | +0.3% | 156,500 |
| 2017/06/28 | 7,230 | 7,270 | 7,190 | 7,200 | -60 | -0.8% | 113,300 |
| 2017/06/27 | 7,260 | 7,320 | 7,220 | 7,260 | -30 | -0.4% | 155,900 |
| 2017/06/26 | 7,220 | 7,330 | 7,210 | 7,290 | +70 | +1% | 131,400 |
| 2017/06/23 | 7,230 | 7,260 | 7,180 | 7,220 | -10 | -0.1% | 153,300 |
| 2017/06/22 | 7,290 | 7,290 | 7,200 | 7,230 | ±0 | ±0% | 199,200 |
| 2017/06/21 | 7,270 | 7,310 | 7,210 | 7,230 | -70 | -1% | 238,700 |
| 2017/06/20 | 7,140 | 7,330 | 7,140 | 7,300 | +230 | +3.3% | 321,500 |
| 2017/06/19 | 7,000 | 7,120 | 6,990 | 7,070 | +90 | +1.3% | 140,300 |
| 2017/06/16 | 6,960 | 7,060 | 6,950 | 6,980 | +100 | +1.5% | 308,000 |
| 2017/06/15 | 6,830 | 6,930 | 6,830 | 6,880 | +90 | +1.3% | 179,800 |
| 2017/06/14 | 6,780 | 6,910 | 6,770 | 6,790 | +90 | +1.3% | 219,700 |
| 2017/06/13 | 6,670 | 6,730 | 6,640 | 6,700 | +30 | +0.4% | 127,800 |
| 2017/06/12 | 6,600 | 6,700 | 6,580 | 6,670 | +50 | +0.8% | 124,200 |
| 2017/06/09 | 6,630 | 6,680 | 6,580 | 6,620 | +10 | +0.2% | 207,100 |
| 2017/06/08 | 6,630 | 6,670 | 6,600 | 6,610 | -10 | -0.2% | 98,600 |
| 2017/06/07 | 6,630 | 6,670 | 6,570 | 6,620 | -40 | -0.6% | 149,700 |
| 2017/06/06 | 6,770 | 6,770 | 6,640 | 6,660 | -120 | -1.8% | 110,700 |
| 2017/06/05 | 6,670 | 6,820 | 6,650 | 6,780 | +120 | +1.8% | 195,200 |
| 2017/06/02 | 6,610 | 6,680 | 6,570 | 6,660 | +70 | +1.1% | 219,400 |
| 2017/06/01 | 6,490 | 6,610 | 6,490 | 6,590 | +130 | +2% | 139,800 |
| 2017/05/31 | 6,400 | 6,520 | 6,400 | 6,460 | ±0 | ±0% | 253,300 |
| 2017/05/30 | 6,520 | 6,520 | 6,420 | 6,460 | -10 | -0.2% | 146,900 |
| 2017/05/29 | 6,510 | 6,520 | 6,450 | 6,470 | -10 | -0.2% | 130,700 |
| 2017/05/26 | 6,510 | 6,530 | 6,460 | 6,480 | -70 | -1.1% | 196,100 |
| 2017/05/25 | 6,510 | 6,570 | 6,500 | 6,550 | -20 | -0.3% | 196,100 |
| 2017/05/24 | 6,610 | 6,630 | 6,550 | 6,570 | -40 | -0.6% | 251,800 |
| 2017/05/23 | 6,660 | 6,700 | 6,600 | 6,610 | +20 | +0.3% | 288,900 |
| 2017/05/22 | 6,680 | 6,680 | 6,570 | 6,590 | -140 | -2.1% | 249,700 |
| 2017/05/19 | 6,740 | 6,760 | 6,660 | 6,730 | +90 | +1.4% | 362,300 |
| 2017/05/18 | 6,620 | 6,700 | 6,590 | 6,640 | +20 | +0.3% | 259,800 |
| 2017/05/17 | 6,500 | 6,640 | 6,490 | 6,620 | +80 | +1.2% | 206,100 |
| 2017/05/16 | 6,540 | 6,580 | 6,480 | 6,540 | -10 | -0.2% | 198,000 |
| 2017/05/15 | 6,420 | 6,550 | 6,410 | 6,550 | +170 | +2.7% | 284,100 |
| 2017/05/12 | 6,110 | 6,400 | 6,110 | 6,380 | +120 | +1.9% | 317,700 |
| 2017/05/11 | 6,260 | 6,350 | 6,250 | 6,260 | -20 | -0.3% | 170,800 |
| 2017/05/10 | 6,260 | 6,300 | 6,190 | 6,280 | +20 | +0.3% | 273,400 |
| 2017/05/09 | 6,180 | 6,300 | 6,160 | 6,260 | +90 | +1.5% | 265,900 |
| 2017/05/08 | 6,140 | 6,200 | 6,110 | 6,170 | +100 | +1.6% | 347,100 |
| 2017/05/02 | 6,000 | 6,090 | 6,000 | 6,070 | +100 | +1.7% | 249,600 |
| 2017/05/01 | 5,940 | 5,980 | 5,920 | 5,970 | +50 | +0.8% | 213,400 |
| 2017/04/28 | 5,920 | 5,970 | 5,890 | 5,920 | -10 | -0.2% | 255,000 |
| 2017/04/27 | 5,910 | 5,960 | 5,890 | 5,930 | +60 | +1% | 341,600 |
| 2017/04/26 | 5,910 | 5,940 | 5,840 | 5,870 | +110 | +1.9% | 316,600 |
| 2017/04/25 | 5,800 | 5,810 | 5,690 | 5,760 | ±0 | ±0% | 222,600 |
2001～
2050
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 374,400円 | +3.8% | -19.9% | 3.63% | 12.16倍 | 0.93倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 203,400円 | +5.9% | +684.6% | 2.70% | 13.50倍 | 1.35倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
